Showing results (1-10 of 74) with videos related to
Sort By:
Pageof 8
Blood Reviews|April 30, 2013
Management of older adults with multiple myelomaAntonio Palumbo, Roberto MinaCurrent Opinion in Oncology|August 22, 2021
The role of autologous stem-cell transplantation in multiple myeloma in 2021Roberto Mina, Francesca GayCancer|April 16, 2019
Is there still a role for stem cell transplantation in multiple myeloma?Roberto Mina, Sagar LonialJournal of the National Comprehensive Cancer Network : JNCCN|January 12, 2013
Part II: role of maintenance therapy in transplant-ineligible patientsAntonio Palumbo, Roberto MinaHematology. American Society of Hematology. Education Program|December 9, 2023
A rational approach to functional high-risk myelomaFrancesca Gay, Giuseppe Bertuglia, Roberto MinaJournal of Clinical Medicine|July 11, 2020
Minimal Residual Disease in Multiple Myeloma: State of the Art and Future PerspectivesRoberto Mina, Stefania Oliva, Mario BoccadoroCancer Journal (Sudbury, Mass.)|September 22, 2021
Minimal Residual Disease in Multiple Myeloma: Ready for Prime Time?Roberto Mina, Francesca Bonello, Stefania OlivaExpert Review of Anticancer Therapy|December 7, 2013
Optimal management of elderly patients with myelomaChiara Cerrato, Roberto Mina, Antonio PalumboJournal of Clinical Medicine|August 23, 2020
Erratum: Mina, R.; et al. Minimal Residual Disease in Multiple Myeloma: State of the Art and Future Perspectives. <i>J. Clin. Med.</i> 2020, <i>9</i>, 2142Roberto Mina, Stefania Oliva, Mario BoccadoroCancers|December 22, 2019
Therapeutic Monoclonal Antibodies and Antibody Products: Current Practices and Development in Multiple MyelomaFrancesca Bonello, Roberto Mina, Mario Boccadoro, et al.Pageof 8